We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Woodward
WWD
$23B
| $38.6M | 0.1% |
497,747
+44,056
| +10% | +$2.88M |
|
252
Alarm.com
ALRM
$2.75B
| $38.3M | 0.09% |
591,235
+181,235
| +44% | +$9.12M |
|
253
Bio-Rad Laboratories Class A
BIO
$8.76B
| $38.3M | 0.09% |
84,777
-47,755
| -36% | -$21.1M |
|
|
EGIO
254
DELISTED
Edgio, Inc. Common Stock
EGIO
| $38.1M | 0.09% |
129,375
+12,309
| +11% | +$2.73M |
|
|
OPLN
255
Openlane
OPLN
$4.28B
| $37.5M | 0.09% |
2,725,840
+821,393
| +43% | +$11.3M |
|
256
Charles River Laboratories
CRL
$11.3B
| $37.1M | 0.09% |
212,773
-9,295
| -4% | -$1.48M |
|
257
Penumbra
PEN
$12.6B
| $37M | 0.09% |
206,981
-31,205
| -13% | -$5.42M |
|
258
Alphabet (Google) Class C
GOOG
$4.11T
| $37M | 0.09% |
522,860
+42,500
| +9% | +$2.87M |
|
|
AMRN
259
Amarin Corp
AMRN
$297M
| $36.7M | 0.09% |
265,015
+93,000
| +54% | +$12.8M |
|
260
Keysight
KEYS
$50.7B
| $36.5M | 0.09% |
361,888
-190,661
| -35% | -$18.7M |
|
261
Applied Materials
AMAT
$347B
| $36.2M | 0.09% |
598,324
+166,912
| +39% | +$9M |
|
|
NATI
262
DELISTED
National Instruments Corp
NATI
| $36.2M | 0.09% |
934,213
-191,501
| -17% | -$7.24M |
|
263
Advanced Drainage Systems
WMS
$10.6B
| $36.1M | 0.09% |
730,499
+466,182
| +176% | +$19.1M |
|
264
Warner Bros
WBD
$64.3B
| $36M | 0.09% |
1,703,985
+278,393
| +20% | +$6.01M |
|
|
SMAR
265
DELISTED
Smartsheet Inc.
SMAR
| $35.9M | 0.09% |
704,766
+4,766
| +0.7% | +$243K |
|
266
Sarepta Therapeutics
SRPT
$1.64B
| $35.9M | 0.09% |
223,790
+25,086
| +13% | +$3.41M |
|
267
Domo
DOMO
$171M
| $35.5M | 0.09% |
1,102,454
+102,345
| +10% | +$2.28M |
|
268
Eli Lilly
LLY
$1.08T
| $35.4M | 0.09% |
215,427
-223,415
| -51% | -$34.3M |
|
269
Zscaler
ZS
$24.9B
| $35.3M | 0.09% |
322,596
+83,796
| +35% | +$6.96M |
|
270
Booz Allen Hamilton
BAH
$8.44B
| $35M | 0.09% |
450,293
+79,818
| +22% | +$6.04M |
|
|
AZUL
271
DELISTED
Azul
AZUL
| $34.9M | 0.09% |
3,120,400
-219,900
| -7% | -$2.12M |
|
272
Genmab
GMAB
$17.5B
| $34.8M | 0.09% |
1,025,462
-38,285
| -4% | -$1.04M |
|
273
Minerva Neurosciences
NERV
$191M
| $34.7M | 0.09% |
1,201,275
| – | – |
|
|
HOLX
274
DELISTED
Hologic
HOLX
| $34.7M | 0.09% |
608,058
-56,214
| -8% | -$2.76M |
|
275
Parker-Hannifin
PH
$120B
| $34.5M | 0.09% |
188,375
+55,578
| +42% | +$8.97M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.